Biomarkers of exposure to fumonisin mycotoxins: A review
- 24 September 2007
- journal article
- review article
- Published by Taylor & Francis Ltd in Food Additives & Contaminants
- Vol. 24 (10), 1196-1201
- https://doi.org/10.1080/02652030701513818
Abstract
The investigation of adverse health effects associated with fungal mycotoxins requires the measurement of human exposure. Most frequently, this exposure is estimated from contamination levels of raw foodstuffs, which are the primary source of toxin exposure, and data on food consumption patterns. However, variations in food preparation methods, food intake, contamination level, intestinal absorption, toxin distribution and excretion lead to individual variations in toxin exposure that are more readily measured with a biomarker. Fumonisin biomarkers have been sought in the measurement of levels of the toxin in physiological samples such as serum, urine, faeces, hair and nails. However, due to the low bioavailability of fumonisin, these samples pose a variety of analytical challenges and also still require validation as biomarkers. The most widely researched fumonisin biomarkers have been those related to the disruption of de novo sphingolipid biosynthesis, namely elevated levels of the sphingoid base, sphinganine, or of its ratio with sphingosine. Elevation of these parameters in humans would potentially provide a biomarker of biochemical effect. A number of investigations into the possible elevation of sphinganine (or its ratio with sphingosine) in human blood and urine have generally failed to correlate with estimates of fumonisin exposure. The sphingoid bases occur naturally in human blood and urine such that their levels have normal ranges, which can be influenced by dietary factors other than fumonisin ingestion. The lower exposures from human diets, as compared with doses in experimental animals, have made detection of changes in these sphingoid biomarkers problematic.Keywords
This publication has 31 references indexed in Scilit:
- Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the SameEnvironmental Health Perspectives, 2006
- Differential Sensitivity of Rat Kidney and Liver to Fumonisin Toxicity: Organ-Specific Differences in Toxin Accumulation and Sphingoid Base MetabolismToxicological Sciences, 2006
- Exposure to Fumonisins and the Occurrence of Neural Tube Defects along the Texas–Mexico BorderEnvironmental Health Perspectives, 2006
- Fumonisin mycotoxins in human hairBiomarkers, 2003
- The determination of fumonisin B1in human faeces: a short term marker for assessment of exposureBiomarkers, 2000
- Mycotoxin-Induced Elevation of Free Sphingoid Bases in Precision-Cut Rat Liver Slices: Specificity of the Response and Structure–Activity RelationshipsToxicology and Applied Pharmacology, 1997
- Fate of a single dose of 14C‐labelled fumonisin B1 in vervet monkeysNatural Toxins, 1995
- Pharmacokinetic fate and pathological effects of14C‐fumonisin B1 in laying hensNatural Toxins, 1994
- Pharmacokinetic fate of 14C‐Labelled fumonisin B1 in SwineNatural Toxins, 1994
- Fusarium moniliformeand Fumonisins in Corn in Relation to Human Esophageal Cancer in TranskeiPhytopathology®, 1992